Omnicell Inc (OMCL) 38.68 $OMCL
Omnicell Has Returned 38.4% Since SmarTrend Recommendation (OMCL)
Comtex SmarTrend(R) - Fri Jul 29, 1:24PM CDT
SmarTrend identified an Uptrend for Omnicell (NASDAQ:OMCL) on April 18th, 2016 at $28.34. In approximately 3 months, Omnicell has returned 38.36% as of today's recent price of $39.21.
OMCL: 38.68 (+2.46)
Omnicell Selected to Provide Interoperable Medication Automation Solutions to Support Patient Safety at Rochester Regional Health
PR Newswire - Thu Jul 28, 3:11PM CDT
Omnicell, Inc. (NASDAQ: OMCL) today announced that Rochester Regional Health ("Rochester Regional"
, a five-hospital health system in western New York, has selected the Company's medication automation solutions for its hospital floors and operating rooms to promote the highest level of patient care. Formed in 2014, Rochester Regional is currently installing Omnicell® automated medication dispensing systems in two of its five hospitals that collectively serve over 1,300 beds, with plans to implement the automation into all five facilities by 2018.
OMCL: 38.68 (+2.46)
Omnicell Achieves Record Revenue in the Second Quarter 2016
PR Newswire - Thu Jul 28, 3:01PM CDT
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions to healthcare systems, today announced results for its second quarter ended June 30, 2016.
OMCL: 38.68 (+2.46)
athenahealth (ATHN) Q2 Earnings Miss Estimates, Stock Down
Zacks Equity Research - Zacks Investment Research - Mon Jul 25, 10:23AM CDT
Shares of athenahealth plunged 12.2% to close at $124.92 on Jul 22, following its second-quarter 2016 results.
FMI: 23.37 (-0.09), QSII: 12.28 (-0.52), OMCL: 38.68 (+2.46), ATHN: 127.79 (-1.09)
Medidata's Payment Solution to Make Reimbursements Easy
Zacks Equity Research - Zacks Investment Research - Tue Jul 19, 6:03AM CDT
Medidata Solutions Inc. recently introduced Medidata Payments, a cloud-based payment technology.
FMI: 23.37 (-0.09), MDSO: 53.15 (-0.09), NVTA: 8.77 (+0.08), OMCL: 38.68 (+2.46)
Evolent Health Hits New 52 Week High, Valence Buy the Key
Zacks Equity Research - Zacks Investment Research - Fri Jul 15, 2:51PM CDT
Shares of Evolent Health Inc (EVH) scaled a new 52-week high of $23.64 on Jul 14.
FMI: 23.37 (-0.09), EVH: 23.54 (+0.18), STRM: 1.46 (-0.07), OMCL: 38.68 (+2.46)
Future of Global Pharmacy Automation Systems Market Lies in Automated Medication Dispensing Systems, Finds TMR
PR Newswire Europe - Fri Jul 15, 8:30AM CDT
ALBANY, New York, July 15, 2016 /PRNewswire/ --
ABC: 85.19 (+0.37), MCK: 194.56 (+1.12), BAX: 48.02 (-0.20), OMCL: 38.68 (+2.46), CERN: 62.39 (+0.15)
Uptrend Call Working As Omnicell Stock Rises 28.2% (OMCL)
Comtex SmarTrend(R) - Thu Jul 14, 1:09PM CDT
SmarTrend identified an Uptrend for Omnicell (NASDAQ:OMCL) on April 18th, 2016 at $28.34. In approximately 3 months, Omnicell has returned 28.23% as of today's recent price of $36.34.
OMCL: 38.68 (+2.46)
Evolent Health (EVH) Buys Valence for $145M, Shares Surge
Zacks Equity Research - Zacks Investment Research - Thu Jul 14, 7:22AM CDT
Shares of Evolent Health (EVH) surged almost 20% to close at $22.35 on Jul 13, after the company announced that it is acquiring Chicago-based Valence Health.
BOX: 11.65 (-0.12), EVH: 23.54 (+0.18), STRM: 1.46 (-0.07), OMCL: 38.68 (+2.46)
Omnicell Grows amid Weak Margins, Hospital Spending Woes
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 8:57AM CDT
On Jun 1, 2016, we issued an updated research report on Omnicell, Inc. (OMCL).
MDSO: 53.15 (-0.09), DRAD: 5.86 (+0.17), OMCL: 38.68 (+2.46), ATHN: 127.79 (-1.09)
Omnicell (OMCL) Q1 Earnings Top Estimates, Margins Drag
Zacks Equity Research - Zacks Investment Research - Mon May 02, 10:05AM CDT
Omnicell, Inc. (OMCL) reported first-quarter 2016 adjusted earnings per share (EPS) of 30 cents, reflecting year-over-year improvement of 57.9%.
MDSO: 53.15 (-0.09), QSII: 12.28 (-0.52), CPSI: 39.64 (-0.52), OMCL: 38.68 (+2.46)
Deutsche Bank 41st Annual Health Care Conference
PR Newswire - Fri Apr 29, 7:07AM CDT
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication and supply management solutions and analytics software for health care facilities, today announced they will present at the Deutsche Bank 41st annual Health Care Conference at the InterContinental Boston Hotel, Boston, MA.
DB: 13.44 (+0.19), OMCL: 38.68 (+2.46)
Omnicell reports 1Q loss
Automated Insights - Thu Apr 28, 4:47PM CDT
MOUNTAIN VIEW, Calif. (AP) _ Omnicell Inc. (OMCL) on Thursday reported a first-quarter loss of $378,000, after reporting a profit in the same period a year earlier.
OMCL: 38.68 (+2.46)
UnityPoint Health® Selects Omnicell Medication Automation, Central Pharmacy and Analytics Solutions to Enhance Patient Safety and Efficiency
PR Newswire - Wed Apr 27, 7:00AM CDT
Omnicell, Inc. (NASDAQ: OMCL) today announced that UnityPoint Health® has awarded the Company a 10-year sole source contract as its provider of medication automation, central pharmacy automation and analytics software across 15 of its facilities. UnityPoint Health expects Omnicell's solutions to advance the highest standards of patient safety and security while optimizing pharmacist, nurse and anesthesiologist workflows. Two benefits offered by Omnicell are the Omnicell Unity enterprise platform, which gives health systems enhanced visibility across multiple Omnicell systems, and interoperability with the Epic electronic health record (EHR) system, which is used by UnityPoint Health. Installation is expected to be completed by the end of the year.
OMCL: 38.68 (+2.46)
Omnicell to Release First Quarter 2016 Earnings Results on April 28th
PR Newswire - Thu Apr 21, 7:00AM CDT
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, will hold a conference call Thursday, April 28, 2016, to discuss the Company's First Quarter 2016 financial results.
OMCL: 38.68 (+2.46)
UW Health Adds New IV Automation Capabilities and Solutions to Enhance Hybrid Drug Distribution Process
PR Newswire - Wed Apr 06, 7:00AM CDT
Omnicell, Inc. (NASDAQ: OMCL) is pleased to report that UW Health, the system associated with the University of Wisconsin-Madison, is adding the i.v.STATION ONCO(TM), which provides robotic sterile compounding of oncology admixtures, to their pharmacy automation solutions. UW Health selected the Aesynt product, now part of Omnicell's product portfolio, for use in the drug distribution process at their main University Hospital as well as in three additional facilities in their health system. In addition, the hospital is updating their existing ROBOT-Rx® automated medication dispensing robot and upgrading their AcuDose-Rx® automated dispensing cabinets. These and other products from Aesynt have recently been added to the Omnicell portfolio, expanding Omnicell's ability to support all key pharmacy distribution models, described as follows:
OMCL: 38.68 (+2.46)
Omnicell Announces New Guided Packing Software Designed to Increase Packing Accuracy of SureMed Multimed Blister Cards which Improve Patient Adherence
PR Newswire - Thu Mar 31, 10:00AM CDT
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and adherence tools to health care systems and pharmacies, today announced general availability of its latest medication adherence solution, the SureMed(TM) by Omnicell® Guided Packing software. This cloud-based software is designed to increase pharmacists' accuracy in filling SureMed multiple medication blister cards, which can improve medication adherence for patients on complex medication regimens. At launch, the software will interface with QS1, one of the most widely used pharmacy information systems (PIS), and is planned to integrate with additional systems later this year.
OMCL: 38.68 (+2.46)
Add Omnicell (OMCL) to Your Investment Portfolio: Here's Why
Zacks Equity Research - Zacks Investment Research - Wed Mar 30, 3:00PM CDT
On Mar 29, 2016, we issued an updated research report on Omnicell, Inc. (OMCL).
MDRX: 14.12 (-0.03), NVTA: 8.77 (+0.08), OMCL: 38.68 (+2.46), ATHN: 127.79 (-1.09)
Omnicell Has Returned 38.4% Since SmarTrend Recommendation (OMCL)
Comtex SmarTrend(R) - Fri Jul 29, 1:24PM CDT
SmarTrend identified an Uptrend for Omnicell (NASDAQ:OMCL) on April 18th, 2016 at $28.34. In approximately 3 months, Omnicell has returned 38.36% as of today's recent price of $39.21.
OMCL: 38.68 (+2.46)
Omnicell Selected to Provide Interoperable Medication Automation Solutions to Support Patient Safety at Rochester Regional Health
PR Newswire - Thu Jul 28, 3:11PM CDT
Omnicell, Inc. (NASDAQ: OMCL) today announced that Rochester Regional Health ("Rochester Regional"
, a five-hospital health system in western New York, has selected the Company's medication automation solutions for its hospital floors and operating rooms to promote the highest level of patient care. Formed in 2014, Rochester Regional is currently installing Omnicell® automated medication dispensing systems in two of its five hospitals that collectively serve over 1,300 beds, with plans to implement the automation into all five facilities by 2018. OMCL: 38.68 (+2.46)
Omnicell Achieves Record Revenue in the Second Quarter 2016
PR Newswire - Thu Jul 28, 3:01PM CDT
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions to healthcare systems, today announced results for its second quarter ended June 30, 2016.
OMCL: 38.68 (+2.46)
athenahealth (ATHN) Q2 Earnings Miss Estimates, Stock Down
Zacks Equity Research - Zacks Investment Research - Mon Jul 25, 10:23AM CDT
Shares of athenahealth plunged 12.2% to close at $124.92 on Jul 22, following its second-quarter 2016 results.
FMI: 23.37 (-0.09), QSII: 12.28 (-0.52), OMCL: 38.68 (+2.46), ATHN: 127.79 (-1.09)
Medidata's Payment Solution to Make Reimbursements Easy
Zacks Equity Research - Zacks Investment Research - Tue Jul 19, 6:03AM CDT
Medidata Solutions Inc. recently introduced Medidata Payments, a cloud-based payment technology.
FMI: 23.37 (-0.09), MDSO: 53.15 (-0.09), NVTA: 8.77 (+0.08), OMCL: 38.68 (+2.46)
Evolent Health Hits New 52 Week High, Valence Buy the Key
Zacks Equity Research - Zacks Investment Research - Fri Jul 15, 2:51PM CDT
Shares of Evolent Health Inc (EVH) scaled a new 52-week high of $23.64 on Jul 14.
FMI: 23.37 (-0.09), EVH: 23.54 (+0.18), STRM: 1.46 (-0.07), OMCL: 38.68 (+2.46)
Future of Global Pharmacy Automation Systems Market Lies in Automated Medication Dispensing Systems, Finds TMR
PR Newswire Europe - Fri Jul 15, 8:30AM CDT
ALBANY, New York, July 15, 2016 /PRNewswire/ --
ABC: 85.19 (+0.37), MCK: 194.56 (+1.12), BAX: 48.02 (-0.20), OMCL: 38.68 (+2.46), CERN: 62.39 (+0.15)
Uptrend Call Working As Omnicell Stock Rises 28.2% (OMCL)
Comtex SmarTrend(R) - Thu Jul 14, 1:09PM CDT
SmarTrend identified an Uptrend for Omnicell (NASDAQ:OMCL) on April 18th, 2016 at $28.34. In approximately 3 months, Omnicell has returned 28.23% as of today's recent price of $36.34.
OMCL: 38.68 (+2.46)
Evolent Health (EVH) Buys Valence for $145M, Shares Surge
Zacks Equity Research - Zacks Investment Research - Thu Jul 14, 7:22AM CDT
Shares of Evolent Health (EVH) surged almost 20% to close at $22.35 on Jul 13, after the company announced that it is acquiring Chicago-based Valence Health.
BOX: 11.65 (-0.12), EVH: 23.54 (+0.18), STRM: 1.46 (-0.07), OMCL: 38.68 (+2.46)
Omnicell Grows amid Weak Margins, Hospital Spending Woes
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 8:57AM CDT
On Jun 1, 2016, we issued an updated research report on Omnicell, Inc. (OMCL).
MDSO: 53.15 (-0.09), DRAD: 5.86 (+0.17), OMCL: 38.68 (+2.46), ATHN: 127.79 (-1.09)
Omnicell (OMCL) Q1 Earnings Top Estimates, Margins Drag
Zacks Equity Research - Zacks Investment Research - Mon May 02, 10:05AM CDT
Omnicell, Inc. (OMCL) reported first-quarter 2016 adjusted earnings per share (EPS) of 30 cents, reflecting year-over-year improvement of 57.9%.
MDSO: 53.15 (-0.09), QSII: 12.28 (-0.52), CPSI: 39.64 (-0.52), OMCL: 38.68 (+2.46)
Deutsche Bank 41st Annual Health Care Conference
PR Newswire - Fri Apr 29, 7:07AM CDT
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication and supply management solutions and analytics software for health care facilities, today announced they will present at the Deutsche Bank 41st annual Health Care Conference at the InterContinental Boston Hotel, Boston, MA.
DB: 13.44 (+0.19), OMCL: 38.68 (+2.46)
Omnicell reports 1Q loss
Automated Insights - Thu Apr 28, 4:47PM CDT
MOUNTAIN VIEW, Calif. (AP) _ Omnicell Inc. (OMCL) on Thursday reported a first-quarter loss of $378,000, after reporting a profit in the same period a year earlier.
OMCL: 38.68 (+2.46)
UnityPoint Health® Selects Omnicell Medication Automation, Central Pharmacy and Analytics Solutions to Enhance Patient Safety and Efficiency
PR Newswire - Wed Apr 27, 7:00AM CDT
Omnicell, Inc. (NASDAQ: OMCL) today announced that UnityPoint Health® has awarded the Company a 10-year sole source contract as its provider of medication automation, central pharmacy automation and analytics software across 15 of its facilities. UnityPoint Health expects Omnicell's solutions to advance the highest standards of patient safety and security while optimizing pharmacist, nurse and anesthesiologist workflows. Two benefits offered by Omnicell are the Omnicell Unity enterprise platform, which gives health systems enhanced visibility across multiple Omnicell systems, and interoperability with the Epic electronic health record (EHR) system, which is used by UnityPoint Health. Installation is expected to be completed by the end of the year.
OMCL: 38.68 (+2.46)
Omnicell to Release First Quarter 2016 Earnings Results on April 28th
PR Newswire - Thu Apr 21, 7:00AM CDT
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, will hold a conference call Thursday, April 28, 2016, to discuss the Company's First Quarter 2016 financial results.
OMCL: 38.68 (+2.46)
UW Health Adds New IV Automation Capabilities and Solutions to Enhance Hybrid Drug Distribution Process
PR Newswire - Wed Apr 06, 7:00AM CDT
Omnicell, Inc. (NASDAQ: OMCL) is pleased to report that UW Health, the system associated with the University of Wisconsin-Madison, is adding the i.v.STATION ONCO(TM), which provides robotic sterile compounding of oncology admixtures, to their pharmacy automation solutions. UW Health selected the Aesynt product, now part of Omnicell's product portfolio, for use in the drug distribution process at their main University Hospital as well as in three additional facilities in their health system. In addition, the hospital is updating their existing ROBOT-Rx® automated medication dispensing robot and upgrading their AcuDose-Rx® automated dispensing cabinets. These and other products from Aesynt have recently been added to the Omnicell portfolio, expanding Omnicell's ability to support all key pharmacy distribution models, described as follows:
OMCL: 38.68 (+2.46)
Omnicell Announces New Guided Packing Software Designed to Increase Packing Accuracy of SureMed Multimed Blister Cards which Improve Patient Adherence
PR Newswire - Thu Mar 31, 10:00AM CDT
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and adherence tools to health care systems and pharmacies, today announced general availability of its latest medication adherence solution, the SureMed(TM) by Omnicell® Guided Packing software. This cloud-based software is designed to increase pharmacists' accuracy in filling SureMed multiple medication blister cards, which can improve medication adherence for patients on complex medication regimens. At launch, the software will interface with QS1, one of the most widely used pharmacy information systems (PIS), and is planned to integrate with additional systems later this year.
OMCL: 38.68 (+2.46)
Add Omnicell (OMCL) to Your Investment Portfolio: Here's Why
Zacks Equity Research - Zacks Investment Research - Wed Mar 30, 3:00PM CDT
On Mar 29, 2016, we issued an updated research report on Omnicell, Inc. (OMCL).
MDRX: 14.12 (-0.03), NVTA: 8.77 (+0.08), OMCL: 38.68 (+2.46), ATHN: 127.79 (-1.09)
